Subhashis Banerjee, Chief Medical Officer of Artiva Biotherapeutics, Inc., filed a Form 4 on November 3, 2026, disclosing a sale of 1,110 shares of common stock on November 2, 2026, to cover tax withholding obligations related to the vesting of restricted stock units.

Key Highlights

  • Reporting person: Subhashis Banerjee, Chief Medical Officer of Artiva Biotherapeutics, Inc.
  • Transaction: 1,110 shares of common stock disposed of (transaction code S) on November 2, 2026
  • Price: $4.1811 per share
  • Post-transaction ownership: 168,738 shares of common stock held directly
  • Purpose: The filing states the sale was made under a company "sell-to-cover" policy to satisfy tax withholding obligations connected to the vesting and release of restricted stock units
  • Automatic transaction: According to the filing, the sales "were automatic and not at the discretion of the Reporting Person"

Banerjee's RSU Vesting Triggers Automatic Share Sale at Artiva Biotherapeutics

According to the Form 4 filed with the SEC on November 3, 2026, Subhashis Banerjee, serving as Chief Medical Officer at Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), disposed of 1,110 shares of common stock on November 2, 2026, at a price of $4.1811 per share. The transaction was coded "S" and recorded as a disposition in Table I of the filing.

The filing's explanation of responses states that Artiva Biotherapeutics has adopted a "sell-to-cover" policy, under which shares are sold automatically to satisfy tax withholding obligations arising from the vesting and release of restricted stock units. The filing explicitly notes that such sales were "automatic and not at the discretion of the Reporting Person." The Form 4 was signed by Jennifer Bush as Attorney-in-Fact on November 3, 2026.

Following the reported transaction, Banerjee directly holds 168,738 shares of Artiva Biotherapeutics common stock, according to the filing. No derivative securities transactions were reported in Table II of the form.

What Was Disclosed

Artiva Biotherapeutics Chief Medical Officer Subhashis Banerjee reported the automatic sale of 1,110 shares at $4.1811 per share on November 2, 2026, to cover RSU-related tax withholding, leaving him with 168,738 shares held directly.